Naiyan Wen

Xinmin Street
Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

ATRX loss promotes gliomagenesis by converged actions on neural differentiation and telomere maintenance.

ATRX loss promotes gliomagenesis by converged actions on neural differentiation and telomere maintenance.

Journal: Cellular signalling

Published: January 06, 2026

Erratum: [Corrigendum] Calcium efflux from the endoplasmic reticulum regulates cisplatin‑induced apoptosis in human cervical cancer HeLa cells.

Erratum: [Corrigendum] Calcium efflux from the endoplasmic reticulum regulates cisplatin‑induced apoptosis in human cervical cancer HeLa cells.

Journal: Oncology letters

Published: April 16, 2025

NONMMUT140591.1 may serve as a ceRNA to regulate Gata5 in UT-B knockout-induced cardiac conduction block.

NONMMUT140591.1 may serve as a ceRNA to regulate Gata5 in UT-B knockout-induced cardiac conduction block.

Journal: Open life sciences

Published: March 31, 2021

Abnormal expression of TGFBR2, EGF, LRP10, and IQGAP1 is involved in the pathogenesis of coronary artery disease.

Abnormal expression of TGFBR2, EGF, LRP10, and IQGAP1 is involved in the pathogenesis of coronary artery disease.

Journal: Reviews in cardiovascular medicine

Published: February 22, 2021

Corrigendum to "RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7" [Biochem. Pharmacol. 180 (2020) 114118].

Corrigendum to "RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7" [Biochem. Pharmacol. 180 (2020) 114118].

Journal: Biochemical pharmacology

Published: October 11, 2020

RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7.

RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7.

Journal: Biochemical pharmacology

Published: April 10, 2020

A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis.

A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis.

Journal: Molecular cancer therapeutics

Published: February 17, 2020

SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway.

SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway.

Journal: International journal of medical sciences

Published: July 15, 2019

Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.

Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.

Journal: International journal of oncology

Published: March 27, 2019

Cepharanthine exerts antitumor activity on choroidal melanoma by reactive oxygen species production and c-Jun N-terminal kinase activation.

Cepharanthine exerts antitumor activity on choroidal melanoma by reactive oxygen species production and c-Jun N-terminal kinase activation.

Journal: Oncology letters

Published: February 24, 2016

miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.

miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: November 09, 2015

Calcium efflux from the endoplasmic reticulum regulates cisplatin-induced apoptosis in human cervical cancer HeLa cells.

Calcium efflux from the endoplasmic reticulum regulates cisplatin-induced apoptosis in human cervical cancer HeLa cells.

Journal: Oncology letters

Published: December 31, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026